Skip to main content
. 2014 Jul 31;49(7):647–662. doi: 10.1310/hpj4907-647

Table 3. Adverse effects (at least 3%) in placebo-controlled studies of dapagliflozin1.

Adverse effects Dapagliflozin 5 mg (n = 1,145) Dapagliflozin 10 mg (n = 1,193) Placebo (n = 1,393)
Female genital mycotic infections 8.4% 6.9% 1.5%
Nasopharyngitis 6.6% 6.3% 6.2%
UTI 5.7% 4.3% 3.7%
Back pain 3.1% 4.2% 3.2%
Increased urination 2.9% 3.8% 1.7%

Note: UTI = urinary tract infection.